首页> 外文OA文献 >Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.
【2h】

Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis.

机译:在一项随机交叉试验中比较两种口服益生菌制剂,突出了副干酪乳杆菌NCC2461对过敏性鼻炎患者的潜在有益作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: There is promising but conflicting evidence to recommend the addition of probiotics to foods for prevention and treatment of allergy. Based on previous studies with fermented milk containing Lactobacillus paracasei NCC2461, we aimed to compare the effect of a powder form of the latter probiotic with the effect of a blend of Lactobacillus acidophilus ATCC SD5221 and Bifidobacterium lactis ATCC SD5219 in patients with allergic rhinitis.METHODS: A double-blind, randomized, cross-over study, involving 31 adults with allergic rhinitis to grass pollen, was performed outside the grass pollen season (registration number: NCT01233154). Subjects received each product for 4-weeks in two phases separated by a wash-out period of 6 to 8 weeks. A nasal provocation test was performed before and after each 4-week product intake period, and outcome parameters (objective and subjective clinical symptoms; immune parameters) were measured during and/or 24 hours after the test.RESULTS: Out of the 31 subject enrolled, 28 completed the study. While no effect was observed on nasal congestion (primary outcome), treatment with NCC2461 significantly decreased nasal pruritus (determined by VAS), and leukocytes in nasal fluid samples, enhanced IL-5, IL-13 and IL-10 production by peripheral blood mononuclear cells in an allergen specific manner and tended to decrease IL-5 secretion in nasal fluid, in contrast to treatment with the blend of L. acidophilus and B. lactis.CONCLUSIONS: Despite short-term consumption, NCC2461 was able to reduce subjective nasal pruritus while not affecting nasal congestion in adults suffering from grass pollen allergic rhinitis. The associated decrease in nasal fluid leukocytes and IL-5 secretion, and the enhanced IL-10 secretion in an allergen specific manner may partly explain the decrease in nasal pruritus. However, somewhat unexpected systemic immune changes were also noted. These data support the study of NCC2461 consumption in a seasonal clinical trial to further demonstrate its potentially beneficial effect.
机译:背景:有希望但相互矛盾的证据建议在食品中添加益生菌以预防和治疗过敏。基于先前对含有副干酪乳杆菌NCC2461的发酵乳的研究,我们旨在比较后者益生菌粉末形式与嗜酸乳杆菌ATCC SD5221和乳酸双歧杆菌ATCC SD5219的混合物对过敏性鼻炎的影响。在草粉花粉季节以外进行了一项双盲,随机,交叉研究,涉及31名成年人对草粉花粉过敏性鼻炎(注册号:NCT01233154)。受试者分两个阶段接受每种产品4周的时间,相隔6-8周的清除期。在每4周产品摄入期之前和之后进行一次鼻激发试验,并在试验后和/或试验后24小时内测量结果参数(客观和主观临床症状;免疫参数)。结果:纳入的31名受试者中,28日完成了研究。虽然未观察到鼻充血(主要结局)的影响,但使用NCC2461治疗可显着减少鼻瘙痒(由VAS确定),并且鼻液样本中的白细胞会增加外周血单核的IL-5,IL-13和IL-10产生与嗜酸乳杆菌和乳酸双歧杆菌的混合物相比,NCC2461能够以过敏原特异的方式减少鼻液中IL-5的分泌。结论:尽管短期食用NCC2461仍能减少主观鼻痒同时不影响患有花粉过敏性鼻炎的成年人的鼻充血。鼻液白细胞和IL-5分泌的相关减少以及以过敏原特异性方式增强的IL-10分泌可能部分解释了鼻瘙痒症的减少。但是,也注意到了一些意想不到的全身免疫变化。这些数据支持季节性临床试验中NCC2461消耗量的研究,以进一步证明其潜在的有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号